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Introduction
Fibroadenoma of the breast is relatively frequent. Women can present with fibroad-
enoma at any age, but the peak incidence is in the second and third decades of life. 
Fibroadenoma is the most common benign breast tumor in adolescent girls and young 
women.1 Growth of fibroadenoma is stimulated by estrogen, progesterone, pregnancy, 
and lactation,2,3 often presents as a palpable mass measuring up to 3 cm, and may 
undergo atrophic changes in menopause.
Fibroadenoma is a biphasic tumor composed of a stromal and an epithelial 
  component. Although, fibroadenoma is generally considered benign, there is evidence 
for an   association with an increased risk of invasive breast cancer.4 Furthermore, pro-
gression of the   epithelial component to carcinoma in situ and invasive carcinoma has 
been documented in the literature.5–8 Malignant transformation from fibroadenoma to 
cancer is rare. Moreover, the risk of developing breast cancer was found to be higher 
in patients with complex fibroadenoma.5 The mean age reported for patients with 
carcinoma arising in fibroadenoma is in the fifth decade, almost 20 years older than 
the peak age of women diagnosed with simple fibroadenoma. Cheatle and Culter were 
the first to describe a carcinoma arising in a fibroadenoma.
Since there are no definite clinical or radiological criteria for diagnosing carcinoma 
arising in a fibroadenoma, histopathological examination should be performed routinely 
to rule out malignancy in cases of nonsimple fibroadenoma.
Case presentation
A 69-year-old woman having one first-degree family member with breast cancer pre-
sented to the breast imaging unit for screening mammography. She had had screening 
mammography every 2 years since 1997, with multiple bilateral benign breast masses 
detected. In 2011, one of the masses in the left breast changed in diameter from 3 cm 
on mammography done in February 2010 (Figure 3) to 5 cm diameter in mammo-
graphy done in May 2011 (Figure 2). Ultrasonography revealed a well-circumscribed 
homogeneous hypoechoic mass 5 cm in diameter (Figure 1). An ultrasound-guided 
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Figure 2 Mammography in May 2011 revealed well-defined, rounded, and oval 
masses, some with coarse calcifications and the largest being 5 cm in diameter 
(white arrow).
Figure 3 Mammography in February 2010 revealed well-defined, rounded and oval 
masses, some with coarse calcifications the largest being 3 cm in diameter (white 
arrow).
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Figure 4 Within the typical fibroadenoma, irregular groups of invasive carcinoma 
cells are seen in the stroma (arrows). Hematoxylin and eosin (He) ×50.
HE × 100
Figure 5 Nests of invasive carcinoma (arrow). Hematoxylin and eosin (He) ×100.
Figure  6  Myoepithelial  cells  are  absent  in  invasive  carcinoma  (black  arrow), 
and myoepithelial cells are preserved in fibroadenoma structures (white arrow). 
Calponin immunostain ×100.
Figure 1 Ultrasonography revealed a well-circumscribed homogeneous hypoechoic 
mass 5 cm in diameter.
core biopsy was taken and examination of the mass revealed 
a fibroadenoma with a focus of invasive ductal carcinoma that 
was completely confined within the fibroadenoma. Computed 
tomography of the chest showed two metastatic nodules in 
the right lung. Abdominal ultrasound and laboratory findings 
were unremarkable. Microscopy revealed fibroadenoma with 
many foci of invasive duct carcinoma (Figure 4). Staining of 
the myoepithelium around tumoral foci with CD10 and actin 
was negative (Figures 5 and 6).
Discussion
Fibroadenomas are common benign lesions of the breast 
that usually present as a single breast mass in young 
women. Simple fibroadenomas have a reported incidence of 
7%–13% in women from adolescence through the mid 20s 
who present to specialty clinics.1 The prevalence of simple 
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fibroadenomas in this age group in the general population is 
reported to be 2.2% and is said to decrease with increasing 
age.7 The incidence of carcinoma within fibroadenoma is 
reported to be 0.1%–0.3% in a screened population, with 
a peak age of occurrence at 42–44 years.7,9,10 Two-thirds of 
carcinomas within fibroadenoma are lobular and one-third are 
ductal or mixed ductal and lobular; lobular carcinoma in situ 
and ductal carcinoma in situ has an approximately equal 
frequency.2,4
Complex fibroadenomas and proliferative disease adja-
cent to fibroadenoma are associated with a slight increase in 
the risk of breast cancer.2,4,11 Invasive ductal carcinoma within 
fibroadenoma is rare.12–15 Although malignant transformation 
of a fibroadenoma is infrequent, the presence of this tumor 
in a woman with a positive family history of breast cancer 
may have greater clinical importance than a fibroadenoma 
arising in a woman with no additional risk factors.   Detection 
of malignancy developing within a fibroadenoma can be 
difficult. Clinical and radiological signs may be masked. 
Physicians should be aware of the potential for progres-
sion of breast fibroadenoma, particularly in women with a 
known BRCA mutation or a strong family history. This case 
report supports the need for a more aggressive diagnostic 
approach towards solid benign-appearing breast lesions in 
women with a strong positive family history of breast and/
or ovarian cancer.
Conclusion
Despite the low percentage of carcinoma occurring within 
fibroadenoma we consider that each lump that changes in 
diameter or echogenicity should be seriously managed; 
extirpation and histological examination are recommended. 
Special caution is warranted in women older than 35 years 
presenting with a fibroadenoma more than 2 cm in diameter. 
The possibility of carcinoma originating within fibroadenoma 
should be considered in cases of lung metastases in women 
with known fibroadenoma.
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